Evidence map›Paper›PMID 41603376›Full record

Trial reportMolecular nutrition & food research2026

Effect of Glucoraphanin on the Abundance of Nrf2 Regulated Genes Within Circulating Small Extracellular Vesicles: A Pilot Dietary Intervention.

Nishantika Mitra, Mark H Vickers, Fiona E Lithander, Anastasiia Artuyants, Cherie Blenkiron, Meika Foster, Hui Hui Phua, Chris Pook, Zeke Wang, Richard F Mithen and 1 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Molecular nutrition & food research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Nishantika MitraLiggins Institute, University of Auckland, Auckland, New Zealand.
Mark H VickersLiggins Institute, University of Auckland, Auckland, New Zealand.
Fiona E LithanderLiggins Institute, University of Auckland, Auckland, New Zealand.
Anastasiia ArtuyantsMolecular Medicine and Pathology, University of Auckland, Auckland, New Zealand.
Cherie BlenkironMolecular Medicine and Pathology, University of Auckland, Auckland, New Zealand.
Meika FosterLiggins Institute, University of Auckland, Auckland, New Zealand.
Hui Hui PhuaLiggins Institute, University of Auckland, Auckland, New Zealand.
Chris PookLiggins Institute, University of Auckland, Auckland, New Zealand.
Zeke WangLiggins Institute, University of Auckland, Auckland, New Zealand.
Richard F MithenLiggins Institute, University of Auckland, Auckland, New Zealand.
Farha RamzanLiggins Institute, University of Auckland, Auckland, New Zealand.

Funding

University of Auckland
6 · The paper itself

Abstract

Cruciferous vegetables, including broccoli, are associated with a reduced risk of age-related chronic diseases. Broccoli accumulates glucoraphanin, which is hydrolyzed to sulforaphane, an isothiocyanate, that activates antioxidant genes via nuclear factor (erythroid-derived 2)-like 2 (Nrf2) transcription factor, thereby alleviating age-related diseases. However, sulforaphane's rapid metabolism and excretion raise questions about its efficacy on peripheral tissues. We hypothesize that consumption of a glucoraphanin-rich broccoli soup induces small extracellular vesicles (sEVs) in the systemic circulation, containing Nrf2-induced antioxidant genes, mediating the effects of broccoli consumption on peripheral tissues. Nine adults participated in a two-arm, single-blinded, randomized crossover trial and consumed a glucoraphanin-rich broccoli soup (intervention) and a control soup. Plasma samples were analyzed to quantify abundance of Nrf2 regulated genes within circulating sEVs, while urine samples were analyzed to determine sulforaphane pharmacokinetics. While sulforaphane was detected in urine following the intervention (p < 0.001), there were no differences in the abundance of Nrf2 regulated genes quantified within circulating sEVs. Urinary sulforaphane profiling confirmed the intervention's efficacy; however, the genes examined were unaltered within circulatory sEVs. Given that EV mRNA does not always relate to function, future studies exploring EV proteomics may provide further insights into sulforaphane's underlying mechanisms.

Indexed as

Extracellular VesiclesGlucosinolatesImidoestersIsothiocyanatesNF-E2-Related Factor 2AdultBrassicaCross-Over StudiesDietFemaleHumansMaleMiddle AgedOximesPilot ProjectsSingle-Blind MethodglucoraphaninGlucosinolatesImidoestersIsothiocyanatesNFE2L2 protein, humanNF-E2-Related Factor 2OximessulforaphaneSulfoxidesdietdietary interventionextracellular vesiclesgenesinflammation

Identifiers

PMID41603376
PMCPMC12848963

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.